======= ATP6AP1 ======= == Gene Information == * **Official Symbol**: ATP6AP1 * **Official Name**: ATPase H+ transporting accessory protein 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=537|537]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q15904|Q15904]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ATP6AP1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ATP6AP1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/300197|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a component of a multisubunit enzyme that mediates acidification of eukaryotic intracellular organelles. Vacuolar ATPase (V-ATPase) is comprised of a cytosolic V1 (site of the ATP catalytic site) and a transmembrane V0 domain. V-ATPase dependent organelle acidification is necessary for such intracellular processes as protein sorting, zymogen activation, and receptor-mediated endocytosis. The encoded protein of this gene may assist in the V-ATPase-mediated acidification of neuroendocrine secretory granules. This protein may also play a role in early development. [provided by RefSeq, Aug 2013]. * **UniProt Summary**: Accessory subunit of the proton-transporting vacuolar (V)-ATPase protein pump, which is required for luminal acidification of secretory vesicles. Guides the V-type ATPase into specialized subcellular compartments, such as neuroendocrine regulated secretory vesicles or the ruffled border of the osteoclast, thereby regulating its activity. Involved in membrane trafficking and Ca(2+)-dependent membrane fusion. May play a role in the assembly of the V-type ATPase complex. In aerobic conditions, involved in intracellular iron homeostasis, thus triggering the activity of Fe(2+) prolyl hydroxylase (PHD) enzymes, and leading to HIF1A hydroxylation and subsequent proteasomal degradation (PubMed:28296633). {ECO:0000269|PubMed:28296633, ECO:0000305|PubMed:27231034}. |ATP-synt S1| |positive regulation of osteoclast development| |plasma membrane proton-transporting V-type ATPase complex| |proton-transporting two-sector ATPase complex| |proton-transporting V-type ATPase, V1 domain| |positive regulation of bone development| |regulation of osteoclast development| |cellular response to increased oxygen levels| |positive regulation of bone resorption| |positive regulation of bone remodeling| |proton-transporting ATP synthase activity, rotational mechanism| |proton-transporting ATPase activity, rotational mechanism| |regulation of bone development| |positive regulation of osteoclast differentiation| |response to increased oxygen levels| |positive regulation of tissue remodeling| |transferrin transport| |transporter activity| |regulation of bone resorption| |pH reduction| |regulation of bone remodeling| |positive regulation of myeloid leukocyte differentiation| |positive regulation of osteoblast differentiation| |cellular iron ion homeostasis| |regulation of osteoclast differentiation| |endoplasmic reticulum-Golgi intermediate compartment membrane| |iron ion transport| |regulation of tissue remodeling| |iron ion homeostasis| |positive regulation of ossification| |insulin receptor signaling pathway| |positive regulation of exocytosis| |regulation of cellular pH| |positive regulation of myeloid cell differentiation| |regulation of pH| |cellular transition metal ion homeostasis| |cellular monovalent inorganic cation homeostasis| |regulation of osteoblast differentiation| |regulation of myeloid leukocyte differentiation| |transition metal ion transport| |transition metal ion homeostasis| |monovalent inorganic cation homeostasis| |proton transmembrane transport| |positive regulation of leukocyte differentiation| |Rab GTPase binding| |cellular response to insulin stimulus| |positive regulation of hemopoiesis| |regulation of ossification| |positive regulation of ERK1 and ERK2 cascade| |endosome membrane| |cellular response to oxygen levels| |regulation of exocytosis| |regulation of myeloid cell differentiation| |response to insulin| |cellular response to peptide hormone stimulus| |regulation of leukocyte differentiation| |regulation of ERK1 and ERK2 cascade| |cellular response to peptide| |establishment of organelle localization| |response to oxygen levels| |response to peptide hormone| |monovalent inorganic cation transport| |positive regulation of secretion by cell| |positive regulation of secretion| |regulation of hemopoiesis| |response to peptide| |transmembrane receptor protein tyrosine kinase signaling pathway| |positive regulation of cell development| |positive regulation of MAPK cascade| |regulation of vesicle-mediated transport| |cellular metal ion homeostasis| |inorganic cation transmembrane transport| |organelle localization| |cellular response to organonitrogen compound| |cellular response to hormone stimulus| |cation transmembrane transport| |metal ion homeostasis| |cellular cation homeostasis| |metal ion transport| |cellular ion homeostasis| |inorganic ion transmembrane transport| |cellular response to nitrogen compound| |cation homeostasis| |enzyme linked receptor protein signaling pathway| |inorganic ion homeostasis| |cellular chemical homeostasis| |regulation of secretion by cell| |regulation of MAPK cascade| |ion homeostasis| |regulation of secretion| |cation transport| |cellular homeostasis| |response to hormone| |regulation of cell development| |endoplasmic reticulum membrane| |ion transmembrane transport| |positive regulation of cell differentiation| |positive regulation of transport| |response to organonitrogen compound| |positive regulation of protein phosphorylation| |positive regulation of intracellular signal transduction| |cellular response to oxygen-containing compound| |positive regulation of phosphorylation| |response to nitrogen compound| |chemical homeostasis| |positive regulation of phosphate metabolic process| |positive regulation of phosphorus metabolic process| |positive regulation of immune system process| |response to abiotic stimulus| |cellular response to endogenous stimulus| |positive regulation of protein modification process| |transmembrane transport| |positive regulation of developmental process| |ion transport| |regulation of protein phosphorylation| |response to endogenous stimulus| |ATP binding| |protein transport| |peptide transport| |response to oxygen-containing compound| |amide transport| |regulation of phosphorylation| |positive regulation of cellular protein metabolic process| |establishment of protein localization| |homeostatic process| |positive regulation of signal transduction| |regulation of immune system process| |positive regulation of protein metabolic process| |positive regulation of multicellular organismal process| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of cell differentiation| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |nitrogen compound transport| |regulation of protein modification process| |regulation of transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp26|Oligomycin-A 20μM R00 exp26]]|-3.24| |[[:results:exp33|Rotenone 2μM R00 exp33]]|-3.17| |[[:results:exp518|RK-33 8μM R08 exp518]]|-2.97| |[[:results:exp441|GSK-J4 1.5μM R08 exp441]]|-2.78| |[[:results:exp17|DABN 20μM R00 exp17]]|-2.77| |[[:results:exp240|Pyridostatin 4μM R05 exp240]]|-2.52| |[[:results:exp448|Ammonium tetrathiomolybdate 10μM R08 exp448]]|-2.48| |[[:results:exp8|Brefeldin A 0.02μM R00 exp8]]|-2.31| |[[:results:exp24|Nocodazole 0.2μM R00 exp24]]|-2.17| |[[:results:exp3|Actinomycin-D 0.001μM R00 exp3]]|-2.15| |[[:results:exp66|BI-D1870 3.15μM R02 exp66]]|-2.13| |[[:results:exp7|Bortezomib 0.05μM R00 exp7]]|-2.09| |[[:results:exp466|Cannabidiol 20μM R08 exp466]]|-2.09| |[[:results:exp19|Etoposide 1μM R00 exp19]]|-2.05| |[[:results:exp155|UNC1999 2μM R03 exp155]]|-2.03| |[[:results:exp531|THZ1 0.06μM R08 exp531]]|-1.99| |[[:results:exp503|Mitomycin-C 0.06μM R08 exp503]]|-1.94| |[[:results:exp244|SB743921 0.001μM R05 exp244]]|-1.91| |[[:results:exp382|Palbociclib 1μM R07 exp382]]|-1.9| |[[:results:exp28|Pimelic-diphenylamide-106 5μM R00 exp28]]|-1.9| |[[:results:exp407|Thapsigargin 0.005μM R07 exp407]]|-1.9| |[[:results:exp539|42°C R08 exp539]]|-1.88| |[[:results:exp116|AICAR 240μM R03 exp116]]|-1.82| |[[:results:exp417|Tubastatin-A 2.5μM R07 exp417]]|-1.79| |[[:results:exp507|Monensin 0.3μM R08 exp507]]|-1.78| |[[:results:exp450|Artemisinin 50μM R08 exp450]]|-1.73| |[[:results:exp113|1-Methyl-nicotinamide-chloride 1000μM R03 exp113]]|-1.72| |[[:results:exp524|Staurosporine 0.02μM R08 exp524]]|-1.71| |[[:results:exp419|Tunicamycin 0.04 to 0.075μM on day4 R07 exp419]]|1.75| |[[:results:exp538|ZLN024 50μM R08 exp538]]|1.77| |[[:results:exp247|UM0130462 0.025 to 0.035μM day4 R05 exp247]]|1.78| |[[:results:exp372|Ibrutinib 1μM R07 exp372]]|1.81| |[[:results:exp72|LB-100 4.1μM R02 exp72]]|1.83| |[[:results:exp534|Trientine 500μM R08 exp534]]|1.85| |[[:results:exp391|Pomalidomide 20μM R07 exp391]]|1.93| |[[:results:exp380|NMS-873 0.07μM R07 exp380]]|1.98| |[[:results:exp169|BH1 1μM R04 exp169]]|1.99| |[[:results:exp179|Combretastatin A4 0.002 to 0.003μM day4 R04 exp179]]|1.99| |[[:results:exp272|CHIR-124 0.04μM R06 exp272]]|2.02| |[[:results:exp78|Pterostilbene 16μM R02 exp78]]|2.08| |[[:results:exp331|A-769662 20μM R07 exp331]]|2.09| |[[:results:exp458|Bisphenol S 100μM R08 exp458]]|2.09| |[[:results:exp79|Q15 2.7μM R02 exp79]]|2.19| |[[:results:exp83|Trametinib 10μM R02 exp83]]|2.26| |[[:results:exp170|Metformin 100 to 150μM on day4 R04 exp170]]|2.67| ^Gene^Correlation^ |[[:human genes:g:golga6l1|GOLGA6L1]]|0.528| |[[:human genes:t:tceb3c|TCEB3C]]|0.503| |[[:human genes:p:psma6|PSMA6]]|0.496| |[[:human genes:s:supt5h|SUPT5H]]|0.491| |[[:human genes:p:psmb4|PSMB4]]|0.486| |[[:human genes:c:ccna2|CCNA2]]|0.485| |[[:human genes:t:tceb3cl|TCEB3CL]]|0.483| |[[:human genes:n:npipb5|NPIPB5]]|0.479| |[[:human genes:t:tceb3cl2|TCEB3CL2]]|0.473| |[[:human genes:t:tsg101|TSG101]]|0.473| |[[:human genes:t:ticrr|TICRR]]|0.473| |[[:human genes:r:rps2|RPS2]]|0.473| |[[:human genes:c:chd4|CHD4]]|0.472| |[[:human genes:c:cdca3|CDCA3]]|0.469| |[[:human genes:o:or10g3|OR10G3]]|0.468| |[[:human genes:a:aqr|AQR]]|0.464| |[[:human genes:c:copg1|COPG1]]|0.459| |[[:human genes:v:vps28|VPS28]]|0.456| |[[:human genes:t:tyms|TYMS]]|0.455| |[[:human genes:c:cdc73|CDC73]]|0.454| |[[:human genes:s:slc6a17|SLC6A17]]|0.451| |[[:human genes:c:crnkl1|CRNKL1]]|0.443| |[[:human genes:n:nupl1|NUPL1]]|0.44| |[[:human genes:a:aamp|AAMP]]|0.436| |[[:human genes:c:cactin|CACTIN]]|0.433| |[[:human genes:p:psmb3|PSMB3]]|0.433| |[[:human genes:p:psmb2|PSMB2]]|0.43| |[[:human genes:p:psmd2|PSMD2]]|0.429| |[[:human genes:d:dtl|DTL]]|0.428| |[[:human genes:n:ndc80|NDC80]]|0.427| |[[:human genes:r:rbbp5|RBBP5]]|0.426| |[[:human genes:z:znf830|ZNF830]]|0.426| |[[:human genes:a:atp6v1c1|ATP6V1C1]]|0.424| |[[:human genes:c:cbwd3|CBWD3]]|0.424| |[[:human genes:r:rpl35|RPL35]]|0.423| |[[:human genes:t:twistnb|TWISTNB]]|0.423| |[[:human genes:p:prim1|PRIM1]]|0.419| |[[:human genes:c:c14orf93|C14orf93]]|0.418| |[[:human genes:k:krt78|KRT78]]|0.418| |[[:human genes:p:pola2|POLA2]]|0.418| |[[:human genes:u:utp3|UTP3]]|0.418| |[[:human genes:t:tfip11|TFIP11]]|0.418| |[[:human genes:p:psma7|PSMA7]]|0.417| |[[:human genes:p:psmc5|PSMC5]]|0.416| |[[:human genes:g:golga8o|GOLGA8O]]|0.416| |[[:human genes:c:col2a1|COL2A1]]|0.416| |[[:human genes:c:cep192|CEP192]]|0.416| |[[:human genes:p:polr2d|POLR2D]]|0.415| |[[:human genes:c:chaf1a|CHAF1A]]|0.414| |[[:human genes:u:utp20|UTP20]]|0.414| |[[:human genes:b:bysl|BYSL]]|0.414| |[[:human genes:t:tuba8|TUBA8]]|0.413| |[[:human genes:a:atp6v0b|ATP6V0B]]|0.413| |[[:human genes:c:copb1|COPB1]]|0.41| |[[:human genes:i:ik|IK]]|0.408| |[[:human genes:t:timeless|TIMELESS]]|0.408| |[[:human genes:t:tbc1d3h|TBC1D3H]]|0.407| |[[:human genes:n:nol10|NOL10]]|0.407| |[[:human genes:h:hinfp|HINFP]]|0.406| |[[:human genes:l:lrr1|LRR1]]|0.406| |[[:human genes:c:cbwd5|CBWD5]]|0.404| |[[:human genes:p:psmd3|PSMD3]]|0.403| |[[:human genes:c:cbwd6|CBWD6]]|0.403| |[[:human genes:l:loxl1|LOXL1]]|0.402| |[[:human genes:k:kctd17|KCTD17]]|0.401| |[[:human genes:e:eif4a3|EIF4A3]]|0.401| |[[:human genes:p:polr2f|POLR2F]]|0.4| Global Fraction of Cell Lines Where Essential: 642/694 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|0/1| |bile duct|27/28| |blood|26/26| |bone|22/26| |breast|26/30| |central nervous system|43/49| |cervix|4/4| |colorectal|16/17| |esophagus|11/11| |fibroblast|1/1| |gastric|12/14| |kidney|15/18| |liver|19/19| |lung|66/72| |lymphocyte|16/16| |ovary|22/25| |pancreas|22/22| |peripheral nervous system|14/15| |plasma cell|12/12| |prostate|1/1| |skin|14/20| |soft tissue|9/9| |thyroid|1/2| |upper aerodigestive|21/22| |urinary tract|27/28| |uterus|5/5| == Essentiality in NALM6 == * **Essentiality Rank**: 378 * **Expression level (log2 read counts)**: 7.02 {{:chemogenomics:nalm6 dist.png?nolink |}}